Rigel Pharmaceuticals (RIGL) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 14, 2026, with virtual attendance available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 13, 2026.

Voting matters and shareholder proposals

• Election of three directors: Alison Hannah, M.D., Walter Moos, Ph.D., and Raul Rodriguez.

• Proposal to amend the 2018 Equity Incentive Plan to add 500,000 shares for issuance.

• Proposal to amend the 2000 Employee Stock Purchase Plan to add 360,000 shares and other changes.

• Advisory vote on executive compensation (say-on-pay).

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Proxy holders authorized to vote on other business as may arise.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals and director nominees.